Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
| Autor: | Steven A, Narod, Jan, Lubinski, Parviz, Ghadirian, Henry T, Lynch, Pal, Moller, William D, Foulkes, Barry, Rosen, Charmaine, Kim-Sing, Claudine, Isaacs, Susan, Domchek, Susan, Domcheck, Ping, Sun |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Oncology medicine.medical_specialty Breast Neoplasms Ethnic origin Breast cancer Risk Factors Internal medicine medicine Humans Mass Screening Mammography skin and connective tissue diseases Prospective cohort study Aged Aged 80 and over BRCA2 Protein Gynecology medicine.diagnostic_test BRCA1 Protein Screening mammography business.industry BRCA mutation Case-control study Odds ratio Middle Aged medicine.disease Case-Control Studies Mutation Female business |
| Zdroj: | The Lancet Oncology. 7:402-406 |
| ISSN: | 1470-2045 |
| DOI: | 10.1016/s1470-2045(06)70624-6 |
| Popis: | Summary Background Screening mammography is associated with a small dose of radiation to the breast, and women with increased genetic risk might be particularly sensitive to the DNA-damaging effects of ionising radiation. We aimed to assess whether exposure to ionising radiation through mammography screening was associated with risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Methods We identified 1600 cases of breast cancer and 1600 controls without breast cancer who were matched for BRCA mutation, date of birth (within 1 year), and country of residence from an international registry of BRCA1 and BRCA2 mutation carriers. We used a questionnaire to inquire about whether participants had ever had screening mammography, and, if so, the age at which they first had the procedure. Results We found no association between ever having screening mammography and risk of breast cancer (odds ratio [OR] 1·03 [95% CI 0·85–1·25], adjusted for parity, oral-contraceptive use, ethnic origin, and bilateral oophorectomy). The association was much the same for BRCA1 mutation carriers and BRCA2 mutation carriers (1·04 [0·84–1·29] vs 1·06 [0·67–1·66], respectively, adjusted for parity, oral-contraceptive use, ethnic origin, and bilateral oophorectomy). Interpretation These findings do not lend support to the idea that exposure to ionising radiation through routine screening mammography contributes substantially to the burden of breast cancer in BRCA1 and BRCA2 mutation carriers. Prospective studies are needed to confirm the results of this initial report, and, where possible, these studies should assess a more appropriate endpoint of total exposure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|